MedTrace Logo

Optimizing Impact of Manual Therapy on Lumbar Spinal Stenosis

NCT06023498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-07

No results posted yet for this study

Summary

Lumbar spinal stenosis, a common condition in older adults, can cause pain and difficulty walking (i.e., intermittent neurogenic claudication - INC). Patients with INC not infrequently undergo spinal surgery that fails to help them 1/3-1/2 the time. The purpose of this multi-site feasibility study is to prepare for the conduct of a randomized controlled trial to test the efficacy of manual therapy, exercise, and intramuscular electroacupuncture in reducing pain and improving walking ability for those with INC, and ultimately limiting the need for surgical referrals.

Conditions

  • Lumbar Spinal Stenosis

Interventions

OTHER

Manual Therapy and Exercise

The 20-minute manual therapy procedures will include: * Distraction-manipulation: manually assisted segmental lumbar traction manipulation using a specialized treatment table * Neural mobilization: rhythmic stretches of the sciatic and femoral nerves75 * Hip, sacroiliac and lumbar facet mobilizations to improve joint mobility * Soft tissue mobilization of lumbopelvic and lower extremity muscles using manual pressure over taut bands/myofascial trigger points and post-isometric (contract-relax) stretching techniques.

OTHER

Intramuscular Electroacupuncture

As described previously

Sponsors & Collaborators

  • Boston Medical Center

    collaborator OTHER

  • VA Pittsburgh Healthcare System

    collaborator FED

  • Syracuse VA Medical Center

    collaborator FED

  • Orlando VA Medical Center

    collaborator FED

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • University of Pittsburgh

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-11
Primary Completion
2026-03-11
Completion
2026-03-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06023498 on ClinicalTrials.gov